LWM
GILD icon

Lyons Wealth Management’s Gilead Sciences GILD Stock Holding History

Lyons Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,800
Closed -$4K – 52
2016
Q3 		$4K Sell
1,800
-4,900
-73% -$398K 0.01% 57
2016
Q2 		$6K Buy
+6,700
New +$595K 0.01% 51
2016
Q1 		– Sell
-1,400
Closed -$4K – 69
2015
Q4 		$4K Buy
+1,400
New +$146K 0.01% 68

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lyons Wealth Management's GILD Position: Q2 2018 in Review

Lyons Wealth Management sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 11,465 shares — an estimated $864K sold.

Lyons Wealth Management first reported a position in GILD in Q1 2015 and held it in 12 quarters. The position peaked at $987K in Q2 2017. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Lyons Wealth Management reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Lyons Wealth Management sold 11,465 Gilead Sciences shares in Q2 2018, an estimated $864K.
  • Lyons Wealth Management first reported a position in Gilead Sciences in Q1 2015 and held it in 12 quarters.
  • Lyons Wealth Management's Gilead Sciences position peaked at $987K in Q2 2017.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Lyons Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.